ITUB20153652A1 - Microsfere contenenti lattoni macrociclici antielminitici - Google Patents
Microsfere contenenti lattoni macrociclici antielminiticiInfo
- Publication number
- ITUB20153652A1 ITUB20153652A1 ITUB2015A003652A ITUB20153652A ITUB20153652A1 IT UB20153652 A1 ITUB20153652 A1 IT UB20153652A1 IT UB2015A003652 A ITUB2015A003652 A IT UB2015A003652A IT UB20153652 A ITUB20153652 A IT UB20153652A IT UB20153652 A1 ITUB20153652 A1 IT UB20153652A1
- Authority
- IT
- Italy
- Prior art keywords
- lattons
- elminitic
- microspheres containing
- containing macrocyclic
- macrocyclic anti
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Feed For Specific Animals (AREA)
- Fats And Perfumes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Priority Applications (20)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2015A003652A ITUB20153652A1 (it) | 2015-09-16 | 2015-09-16 | Microsfere contenenti lattoni macrociclici antielminitici |
| HUE16770213A HUE052553T2 (hu) | 2015-09-16 | 2016-09-06 | Anthelmintikus hatású makrociklusos laktonokat tartalmazó mikrogömbök |
| PL16770213T PL3349726T3 (pl) | 2015-09-16 | 2016-09-06 | Mikrosfery zawierające przeciwrobacze laktony makrocykliczne |
| KR1020247021000A KR102752755B1 (ko) | 2015-09-16 | 2016-09-06 | 구충제 마크로시클릭 락톤을 포함하는 미세구 |
| PCT/EP2016/070921 WO2017045966A1 (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
| LTEP16770213.3T LT3349726T (lt) | 2015-09-16 | 2016-09-06 | Mikrosferos, turinčios antihelmintinių makrociklinių laktonų |
| HRP20201783TT HRP20201783T1 (hr) | 2015-09-16 | 2016-09-06 | Mikrosfere koje sadrže anthelmintske makrocikličke laktone |
| ES16770213T ES2848559T3 (es) | 2015-09-16 | 2016-09-06 | Microesferas que contienen lactonas macrocíclicas antihelmínticas |
| EP16770213.3A EP3349726B1 (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
| RS20201395A RS61100B1 (sr) | 2015-09-16 | 2016-09-06 | Mikrosfere koje sadrže antelmintične makrociklične laktone |
| AU2016321801A AU2016321801B2 (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
| DK16770213.3T DK3349726T3 (da) | 2015-09-16 | 2016-09-06 | Mikrosfærer indeholdende antihelmintiske makrocykliske lactoner |
| KR1020177035710A KR20180052559A (ko) | 2015-09-16 | 2016-09-06 | 구충제 마크로시클릭 락톤을 포함하는 미세구 |
| SM20200625T SMT202000625T1 (it) | 2015-09-16 | 2016-09-06 | Microsfere contenenti lattoni macrociclici antielmintici |
| SI201630970T SI3349726T1 (sl) | 2015-09-16 | 2016-09-06 | Mikrosfere, ki vsebujejo antihelmintske makrociklične laktone |
| JP2017564811A JP6781717B2 (ja) | 2015-09-16 | 2016-09-06 | 駆虫薬の大環状ラクトンを含むミクロスフェア |
| US15/735,233 US10603278B2 (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
| CA2989092A CA2989092C (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
| PT167702133T PT3349726T (pt) | 2015-09-16 | 2016-09-06 | Microsferas que contêm lactonas macrocíclicas antihelmínticas |
| CY20201101059T CY1123554T1 (el) | 2015-09-16 | 2020-11-10 | Μικροσφαιριδια που περιεχουν αντιελμινθικες μακροκυκλικες λακτονες |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2015A003652A ITUB20153652A1 (it) | 2015-09-16 | 2015-09-16 | Microsfere contenenti lattoni macrociclici antielminitici |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITUB20153652A1 true ITUB20153652A1 (it) | 2017-03-16 |
Family
ID=54884228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITUB2015A003652A ITUB20153652A1 (it) | 2015-09-16 | 2015-09-16 | Microsfere contenenti lattoni macrociclici antielminitici |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10603278B2 (it) |
| EP (1) | EP3349726B1 (it) |
| JP (1) | JP6781717B2 (it) |
| KR (2) | KR102752755B1 (it) |
| AU (1) | AU2016321801B2 (it) |
| CA (1) | CA2989092C (it) |
| CY (1) | CY1123554T1 (it) |
| DK (1) | DK3349726T3 (it) |
| ES (1) | ES2848559T3 (it) |
| HR (1) | HRP20201783T1 (it) |
| HU (1) | HUE052553T2 (it) |
| IT (1) | ITUB20153652A1 (it) |
| LT (1) | LT3349726T (it) |
| PL (1) | PL3349726T3 (it) |
| PT (1) | PT3349726T (it) |
| RS (1) | RS61100B1 (it) |
| SI (1) | SI3349726T1 (it) |
| SM (1) | SMT202000625T1 (it) |
| WO (1) | WO2017045966A1 (it) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102101969B1 (ko) * | 2017-09-06 | 2020-04-22 | (주)인벤티지랩 | 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법 |
| MX2021010043A (es) | 2019-02-21 | 2022-07-19 | Chromadex Inc | Uso de nicotinamida ribósido, ácido nicotinico ribósido, compuestos de nicotinil ribósido reducido y derivados de compuestos de nicotinil ribósido en formulaciones. |
| CA3138263A1 (en) * | 2019-05-03 | 2020-11-12 | Intervet International B.V. | Injectable pharmaceutical compositions and uses thereof |
| PT4153133T (pt) * | 2020-05-20 | 2024-01-12 | Intervet Int Bv | Composições farmacêuticas injetáveis e utilizações das mesmas |
| JP2025521784A (ja) | 2022-06-30 | 2025-07-10 | ヴィルバック | Pk/pd相互作用に関連する非ヒト哺乳類の化学的去勢におけるデスロレリンの使用 |
| CN115040487B (zh) * | 2022-07-04 | 2023-04-25 | 湖北工业大学 | 一种几丁质酶响应性伊维菌素微球及其制备方法和应用 |
| CN116531337A (zh) * | 2023-04-20 | 2023-08-04 | 中国农业科学院兰州畜牧与兽药研究所 | 一种莫西菌素缓释微球及其制备方法和应用 |
| WO2025190964A1 (en) | 2024-03-12 | 2025-09-18 | Virbac | Parenteral modoflaner for the control of ectoparasites |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0525307A1 (en) * | 1991-07-23 | 1993-02-03 | American Cyanamid Company | Stable compositions for parenteral administration and their use |
| WO1999043304A1 (en) * | 1998-02-25 | 1999-09-02 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
| EP1197207A2 (en) * | 2000-10-10 | 2002-04-17 | American Cyanamid Company | Stable compositions for parenteral administration |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2054664T3 (es) | 1986-03-12 | 1994-08-16 | American Cyanamid Co | Compuestos macrolidos. |
| DE3750355T2 (de) | 1986-09-12 | 1995-04-06 | American Cyanamid Co | 23-Oxo(keto) und 23-Imino-Derivate von LL-F28249-Verbindungen. |
| FR2663224B1 (fr) * | 1990-06-14 | 1995-01-20 | Applicationes Farmaceuticas Sa | Forme galenique parenterale. |
| PL339864A1 (en) | 1997-09-30 | 2001-01-15 | Lilly Co Eli | Preparation containing 2-methylthiene benzodiazepin |
| AU781682B2 (en) | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
| UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| AUPR602501A0 (en) | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
| SI1844765T1 (sl) * | 2003-06-13 | 2015-05-29 | Skendi Finance, Ltd. | Formulacija estradiola in progesterona s počasnim sproščanjem |
| KR20140136005A (ko) | 2012-03-13 | 2014-11-27 | 바이엘 뉴질랜드 리미티드 | 지속성 조성물 |
-
2015
- 2015-09-16 IT ITUB2015A003652A patent/ITUB20153652A1/it unknown
-
2016
- 2016-09-06 CA CA2989092A patent/CA2989092C/en active Active
- 2016-09-06 AU AU2016321801A patent/AU2016321801B2/en active Active
- 2016-09-06 WO PCT/EP2016/070921 patent/WO2017045966A1/en not_active Ceased
- 2016-09-06 PL PL16770213T patent/PL3349726T3/pl unknown
- 2016-09-06 JP JP2017564811A patent/JP6781717B2/ja active Active
- 2016-09-06 HR HRP20201783TT patent/HRP20201783T1/hr unknown
- 2016-09-06 SI SI201630970T patent/SI3349726T1/sl unknown
- 2016-09-06 LT LTEP16770213.3T patent/LT3349726T/lt unknown
- 2016-09-06 DK DK16770213.3T patent/DK3349726T3/da active
- 2016-09-06 SM SM20200625T patent/SMT202000625T1/it unknown
- 2016-09-06 EP EP16770213.3A patent/EP3349726B1/en active Active
- 2016-09-06 US US15/735,233 patent/US10603278B2/en active Active
- 2016-09-06 KR KR1020247021000A patent/KR102752755B1/ko active Active
- 2016-09-06 RS RS20201395A patent/RS61100B1/sr unknown
- 2016-09-06 ES ES16770213T patent/ES2848559T3/es active Active
- 2016-09-06 PT PT167702133T patent/PT3349726T/pt unknown
- 2016-09-06 HU HUE16770213A patent/HUE052553T2/hu unknown
- 2016-09-06 KR KR1020177035710A patent/KR20180052559A/ko not_active Ceased
-
2020
- 2020-11-10 CY CY20201101059T patent/CY1123554T1/el unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0525307A1 (en) * | 1991-07-23 | 1993-02-03 | American Cyanamid Company | Stable compositions for parenteral administration and their use |
| WO1999043304A1 (en) * | 1998-02-25 | 1999-09-02 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
| EP1197207A2 (en) * | 2000-10-10 | 2002-04-17 | American Cyanamid Company | Stable compositions for parenteral administration |
Also Published As
| Publication number | Publication date |
|---|---|
| HUE052553T2 (hu) | 2021-05-28 |
| KR20180052559A (ko) | 2018-05-18 |
| CY1123554T1 (el) | 2022-03-24 |
| CA2989092C (en) | 2023-10-03 |
| KR102752755B1 (ko) | 2025-01-10 |
| CA2989092A1 (en) | 2017-03-23 |
| US20180177730A1 (en) | 2018-06-28 |
| DK3349726T3 (da) | 2020-11-23 |
| KR20240108529A (ko) | 2024-07-09 |
| PL3349726T3 (pl) | 2021-04-06 |
| PT3349726T (pt) | 2020-11-23 |
| EP3349726B1 (en) | 2020-11-04 |
| US10603278B2 (en) | 2020-03-31 |
| WO2017045966A1 (en) | 2017-03-23 |
| EP3349726A1 (en) | 2018-07-25 |
| RS61100B1 (sr) | 2020-12-31 |
| SI3349726T1 (sl) | 2020-12-31 |
| SMT202000625T1 (it) | 2021-01-05 |
| LT3349726T (lt) | 2021-02-10 |
| AU2016321801B2 (en) | 2021-11-25 |
| JP2018527291A (ja) | 2018-09-20 |
| JP6781717B2 (ja) | 2020-11-04 |
| AU2016321801A1 (en) | 2018-01-04 |
| HRP20201783T1 (hr) | 2021-01-22 |
| ES2848559T3 (es) | 2021-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3331869T3 (da) | Muscarinagonister | |
| DK3331528T3 (da) | Muskarinagonister | |
| DK3277719T3 (da) | Polypeptider | |
| EP3316375A4 (en) | Redox flow cell | |
| DK3305788T3 (da) | Janus-kinase-hæmmer | |
| DK3129350T3 (da) | Makrocyklusser | |
| DK3360890T3 (da) | Genterapi | |
| DK3331529T3 (da) | Muskarinagonister | |
| EP3290364A4 (en) | Conveyor belt wear monitoring system | |
| DK3310450T3 (da) | Olie-vand-separator | |
| KR20180084915A (ko) | 구조체 | |
| DK3270930T3 (da) | Præeklampsi | |
| DK3394281T3 (da) | Gærcelle | |
| EP3381654A4 (en) | Liquid blow molding method | |
| ITUB20153652A1 (it) | Microsfere contenenti lattoni macrociclici antielminitici | |
| EP3393959A4 (en) | GRAB | |
| EP3343603A4 (en) | STRUCTURE | |
| EP3363322A4 (en) | Hair extender | |
| EP3308781A4 (en) | BLOOD PRESSURE CENTER | |
| EP3390240A4 (en) | LOADING STRUCTURE | |
| DE112015006486A5 (de) | Inkubationsrinne | |
| EP3390373C0 (en) | DOTA SUMMARY | |
| EP3548009A4 (en) | POLYMERIC NANOPARTICLES | |
| DK3274482T3 (da) | Stenborsknop | |
| EP3377179A4 (en) | DEUTERED EPI-743 |